Edwards Lifesciences Corp

$85.50

0.56 (0.65%) Today

0.79 (0.92%) After-hours

— up— down

Compare EW

Market Cap

$49.74B+13.2%

Revenue (TTM)

$6.49B+14.6%

Net Income (TTM)

$995.27M-75.2%

EPS (TTM)

1.73-75.2%

Shares Out

575.80M

P/E Ratio

49.49

Forward P/E

28.75

Open

$86.29

Previous Close

$85.73

Day Range

$84.93 – $87.11

52-Week Range

$72.30 – $96.29

Beta

0.85

Volume

3.60M

Avg Volume

4.31M

Analyst Rating

Buy

Exchange

NEW YORK STOCK EXCHANGE, INC.

About EW

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.